AlpenGlobal Capital LLC Purchases 3,612 Shares of iShares Biotechnology ETF $IBB

AlpenGlobal Capital LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,612 shares of the financial services provider’s stock, valued at approximately $760,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in IBB. Kaydan Wealth Management Inc. boosted its stake in iShares Biotechnology ETF by 3.9% during the 3rd quarter. Kaydan Wealth Management Inc. now owns 1,363 shares of the financial services provider’s stock worth $287,000 after acquiring an additional 51 shares during the last quarter. Carter Financial Group INC. boosted its position in shares of iShares Biotechnology ETF by 2.2% during the second quarter. Carter Financial Group INC. now owns 2,423 shares of the financial services provider’s stock worth $461,000 after purchasing an additional 53 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of iShares Biotechnology ETF by 8.8% in the 1st quarter. Parallel Advisors LLC now owns 744 shares of the financial services provider’s stock valued at $126,000 after buying an additional 60 shares during the period. Apollon Wealth Management LLC grew its holdings in shares of iShares Biotechnology ETF by 0.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 8,178 shares of the financial services provider’s stock valued at $1,722,000 after buying an additional 60 shares during the period. Finally, Global Assets Advisory LLC grew its holdings in shares of iShares Biotechnology ETF by 3.1% in the 3rd quarter. Global Assets Advisory LLC now owns 2,082 shares of the financial services provider’s stock valued at $432,000 after buying an additional 62 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $212.50 on Friday. iShares Biotechnology ETF has a 12 month low of $159.68 and a 12 month high of $222.29. The company has a fifty day simple moving average of $208.95 and a 200 day simple moving average of $186.91.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were given a dividend of $0.0112 per share. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 annualized dividend and a dividend yield of 0.0%. The ex-dividend date of this dividend was Tuesday, September 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.